CYP46 activators constitute a specialized class of chemical compounds known for their ability to modulate the activity of the enzyme CYP46A1, also known as cholesterol 24-hydroxylase. CYP46A1 is a member of the cytochrome P450 enzyme family, primarily expressed in the brain, where it plays a pivotal role in cholesterol homeostasis. These activators are meticulously designed to interact with CYP46A1, influencing its enzymatic function and, in turn, affecting cholesterol metabolism in neural tissues. At the molecular level, the mechanisms underlying CYP46 activation can be multifaceted, often involving binding to specific regions of the enzyme's structure, potentially inducing conformational changes that enhance its catalytic activity and specificity for cholesterol substrates.
The study of CYP46 activators is instrumental in advancing our understanding of cholesterol regulation within the brain and its potential implications for neurological health. Researchers in this field primarily focus on elucidating the precise molecular mechanisms by which these compounds impact CYP46A1 function and their downstream effects on cholesterol metabolism. Understanding the role of CYP46 activators contributes to our broader knowledge of lipid biology, particularly in the context of the central nervous system, and how cholesterol homeostasis influences brain function. Moreover, these compounds serve as valuable tools for scientists seeking to investigate the molecular basis of cholesterol metabolism in the brain, ultimately deepening our understanding of the intricate molecular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $30.00 $87.00 $132.00 $434.00 | 13 | |
Inhibitors of HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis; might upregulate CYP46 as a compensatory mechanism to clear cholesterol. | ||||||
T 0901317 | 293754-55-9 | sc-202824 sc-202824A | 10 mg 50 mg | $87.00 $220.00 | 5 | |
Liver X receptors (LXRs) are nuclear receptors that regulate genes involved in cholesterol homeostasis; activation might influence CYP46 expression. | ||||||
Fatostatin | 125256-00-0 | sc-507496 | 100 mg | $450.00 | ||
Sterol regulatory element-binding proteins (SREBPs) are transcription factors involved in cholesterol synthesis; inhibiting them might indirectly affect CYP46. | ||||||
25-Hydroxycholesterol | 2140-46-7 | sc-214091B sc-214091 sc-214091A sc-214091C | 5 mg 10 mg 25 mg 100 mg | $52.00 $89.00 $166.00 $465.00 | 8 | |
Oxysterol that can modulate the activity of LXRs; might influence CYP46 expression. | ||||||
Geranylgeraniol | 24034-73-9 | sc-200858 sc-200858A | 20 mg 100 mg | $159.00 $465.00 | 14 | |
A metabolite in the mevalonate pathway, which is inhibited by statins; might indirectly influence CYP46. | ||||||
Desmosterol | 313-04-2 | sc-214871 sc-214871A | 5 mg 10 mg | $92.00 $162.00 | 1 | |
An immediate precursor to cholesterol; its accumulation might signal a need to upregulate CYP46. | ||||||
CHOLESTYRAMINE RESIN | 11041-12-6 | sc-507509 | 5 g | $210.00 | ||
Bile acid sequestrant; by sequestering bile acids, it might indirectly influence CYP46 expression via altered cholesterol metabolism. | ||||||
Ezetimibe | 163222-33-1 | sc-205690 sc-205690A | 25 mg 100 mg | $94.00 $236.00 | 12 | |
Inhibitor of dietary cholesterol absorption; could affect CYP46 indirectly by altering brain cholesterol levels. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $140.00 $500.00 | 2 | |
Induces cholesterol accumulation in cells; might upregulate CYP46 as a compensatory response. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $28.00 $88.00 $332.00 | 12 | |
Another statin that inhibits HMG-CoA reductase; potential to upregulate CYP46. | ||||||